- Home
- SNN
as 12-20-2024 4:00pm EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.0B | IPO Year: | 1999 |
| Target Price: | N/A | AVG Volume (30 days): | 740.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.35 | EPS Growth: | 39.77 |
| 52 Week Low/High: | $23.65 - $31.72 | Next Earning Date: | 08-01-2024 |
| Revenue: | $5,642,000,000 | Revenue Growth: | 5.48% |
| Revenue Growth (this year): | 6.97% | Revenue Growth (next year): | 5.46% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
GlobeNewswire
3 days ago
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
Zacks
5 days ago
SNN Stock Might Rise Following FDA Nod for AETOS Stemless
MT Newswires
6 days ago
Smith & Nephew Gets US FDA's Premarket Clearance for Stemless Shoulder Implant
GlobeNewswire
6 days ago
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
Simply Wall St.
6 days ago
3 UK Stocks Estimated To Be Trading At Discounts Of Up To 38.7%
MedTech Dive
16 days ago
Smith & Nephew laying off about 150 employees in Tennessee
Simply Wall St.
21 days ago
Smith & Nephew plc (LON:SN.) is a favorite amongst institutional investors who own 77%
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.